Blackhawk’s Asthmatic AI Progresses in Clinical Trials
Company Announcements

Blackhawk’s Asthmatic AI Progresses in Clinical Trials

Blackhawk Resource (TSE:BLR) has released an update.

Blackhawk Growth Corp. announces significant progress with its affiliate, Asthmatic AI, completing trials with 50 participants and advancing to tests with 250 more individuals for its pioneering asthma attack prediction technology. This innovative approach integrates wearable devices and smartphone apps to preemptively address asthma attacks by analyzing personal health data alongside environmental factors. Additionally, the Hardenbrook Group is consolidating its health-tech AI ventures, including Asthmatic AI, with plans for Life AI Corp to serve as a holding entity and future public listing.

For further insights into TSE:BLR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBlackhawk Growth Backs Innovative AI Health Technologies
TipRanks Canadian Auto-Generated NewsdeskBlackhawk Prepares for Rebranding and Tech Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App